Podcast Episodes
Back to Search
Episode 424: ASCO 2025 - Emergency podcast on the prostate rapid oral session
Jorge Garcia joins us to discuss the process of selecting abstracts for oral presentation and select highlights from this session.
1 year, 4 months ago
Episode 423: ASCO 2025 - Casdatifan plus Cabo in refractory RCC
Toni Choueiri discusses this combination cohort of HIF inhibition plus VEGF-R inhibition.
1 year, 4 months ago
Episode 422: ACSO 2025 - ctDNA data from NIAGARA
Matt Galsky discusses the ASCO 2025 data regarding ctDNA from the NIAGARA neoadjuvant chemo +/- durvalumab study.
1 year, 4 months ago
Episode 421: ASCO 2025 - Maintenance Avelumab +/- SG in Advanced Bladder Cancer
Jeannie Hoffman-Censits discusses her randomized phase 2 adding SG to maintenence avelumab in mUC.
1 year, 4 months ago
Episode 420: ASCO 2025 - CheckMate 901: Ipi/Nivo vs chemo for Cis-ineligible metastatic urothelial cancer
Michiel Van Der Heijden joins us to discuss the Ipi/Nivo vs chemo randomization in this trial from his ASCO 2025 presentation
1 year, 4 months ago
Episode 419: ASCO 2025 - Correlate data from the IMmotion 010 RCC adjuvant study
Monty Pal discusses more correlates from this trial including matched baseline and progression tissue samples.
1 year, 4 months ago
Episode 418: ASCO 2025 - Biomarkers in RCC
David McDermott joins us on the heels of his outstanding discussion of the clinical science symposium on RCC biomarkers.
1 year, 4 months ago
Episode 417: ASCO25 GUの注目演題について3人でDiscussion！！
Practice Changing? 独断と偏見で選んだ注目演題について結果の予想も含めて議論しました。
1 year, 5 months ago
Episode 416: ASCO 2025 Preview
Silke, Tom and Brian discuss what they are looking forward to at ASCO 2025
1 year, 5 months ago
Episode 415: Uromigos Score 前立腺がん編
日本と海外の違いはあるのか？mHSPCとmCRPCのUromigos Scoreについて激論！！
1 year, 5 months ago